文献速递头颈外科耳科与耳神经鼻科

特定耳鼻咽喉科手术术后纳洛酮使用对新发物质使用障碍、过量及死亡的影响

The Effect of Postoperative Naloxone in Certain Otolaryngologic Surgeries.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-12-20

基于TriNetX数据库的回顾性队列研究,纳入2003年1月至2023年4月接受扁桃体、甲状腺/甲状旁腺、鼻整形、耳科/神经耳科、鼻窦/前颅底及头颈癌手术的成年患者共2,305,655例,比较术后使用纳洛酮与未使用者6个月内新发物质使用障碍、过量及死亡的比值。匹配人口学变量及共病后,上述关联减弱(P>.01),提示术后纳洛酮可能未显著影响这些结局。

要点

  • 研究共纳入2,305,655例患者,平均年龄36.7±19.5岁,46%为女性。
  • 匹配前队列新发物质使用障碍比值相当、过量比值升高、死亡比值不一;匹配后效应减弱(P>.01)。
  • 作者认为,在控制既往物质使用障碍与精神疾病后,术后纳洛酮可能未显著影响新发物质使用障碍、过量及死亡。

核心结论

  • 作者认为,在控制既往物质使用障碍与精神疾病后,术后纳洛酮可能未显著影响特定耳鼻咽喉科手术的新发物质使用障碍、过量及死亡。
  • 临床医生在制定术后疼痛管理方案时应了解这些共病,方案中可包含或不包含纳洛酮。

研究设计与样本

  • 回顾性队列数据库研究,数据来自TriNetX。
  • 纳入2003年1月至2023年4月接受扁桃体手术(非癌性)、甲状腺/甲状旁腺、鼻整形、耳科/神经耳科、鼻窦/前颅底及头颈癌手术的成年患者。
  • 排除术前病历中记录有物质使用障碍或过量、或在该6个月时间窗内接受过另一手术的患者。
  • 共纳入2,305,655例患者,平均年龄36.7±19.5岁,46%为女性。

主要发现

  • 匹配前,各队列新发物质使用障碍的比值相当,过量的比值升高,死亡的比值不一。
  • 按人口学变量及共病(其他物质使用、因其他疾病使用阿片类药物、精神疾病)匹配后,这些效应减弱(P>.01)。
  • P<.01被视为具有统计学显著性。

临床怎么用

  • 作者建议临床医生在考虑术后疼痛管理方案时了解既往物质使用障碍与精神疾病等共病,方案可包含或不包含纳洛酮。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association of postoperative naloxone with the development of new substance use disorder (SUD), overdose, and death within 6 months of otolaryngologic surgery. STUDY DESIGN: Retrospective cohort database study on TriNetX. METHODS: Adult patients who underwent tonsil surgery (noncancerous), thyroid/parathyroid, septorhinoplasty, otology/neurotology, sinus/anterior skull base, and head and neck cancer surgeries between January 2003 and April 2023. Patients were excluded if they had an instance of SUD or overdose recorded in their charts prior to surgery, or had undergone another surgery within that 6-month time frame. We hypothesized that patients prescribed naloxone postoperatively would have decreased odds for experiencing new SUD, overdose, and/or death within 6 months of surgery compared to patients who did not receive naloxone. P < .01 was considered statistically significant. RESULTS: There were 2,305,655 patients in this study. The average age was 36.7 ± 19.5 years old, with 46% female patients. Before matching, cohorts showed equivocal odds for developing new SUD, increased odds for overdose, and mixed odds for dying. After matching for demographic variables and comorbidities such as other substance use, opioid use for other pathologies, and psychiatric conditions, these effects diminished (P > .01). CONCLUSION: Our results suggest that postoperative naloxone may not significantly affect development of new SUD and incident overdose and death in certain otolaryngologic surgeries after controlling for prior SUD and psychiatric conditions. Clinicians should be aware of these comorbidities when considering their postoperative pain management protocol, which may or may not include naloxone.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Perlov NM, Shah SS, Bluj J, et al. The Effect of Postoperative Naloxone in Certain Otolaryngologic Surgeries. Otolaryngol Head Neck Surg. 2023. PMID: 38123881. doi:10.1002/ohn.625

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。